CrystalGenomics - a global biopharma company focused on novel drug development. We focus on improving patients' quality of life through the development of innovative drugs for diseases with high unmet needs. Established in 2000 and publicly traded since 2006 (KOSDAQ), CrystalGenomics is Korea's leading biopharma company, deeply invested in developing new drugs. Our drug discovery program is driven by our core technologies: Sol...
CrystalGenomics - a global biopharma company focused on novel drug development. We focus on improving patients' quality of life through the development of innovative drugs for diseases with high unmet needs. Established in 2000 and publicly traded since 2006 (KOSDAQ), CrystalGenomics is Korea's leading biopharma company, deeply invested in developing new drugs. Our drug discovery program is driven by our core technologies: Soluble Protein Solution (SPS™) - to identify the structure of target proteins for intervention and Structural ChemoProteomics (SCP™) - to efficiently identify potential novel drug leads.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.